The 2018 Optimal Pregnancy Environment Risk Assessment (OPERA) Europe Workshop will take place in Pforzheim, Germany and Metabolomic Diagnostics will present at the event.
OPERA is an international interdisciplinary program of researchers, care providers, foundations and agencies dedicated to discovering and disseminating inexpensive and accessible tolls to diagnose those women and their new-borns at risk for preterm birth or other adverse pregnancy or new-born health outcomes as early as possible in pregnancy and to promoting effective interventions to mitigate these risks.
Dr Robin Tuytten, PhD, the VP of R&D at Metabolomic Diagnostics, will present on
“BioMarkers for Predicting Pre-eclampsia”
Dr Tuytten will give a review on the development of Metabolomic Diagnostic’s pre-eclampsia risk stratification/prediction test and how first-time pregnant women benefit most from it.
Tuesday, 11th December 2018 at 5th floor conference room, Helios Hospital, Pforzheim, Germany
13:30 – 15:10 Session III – Addressing and predicting risk
Chair: Kelycia Leimert